Construction of zinc-α2-glycoprotein expression plasmid and its expression in 3T3-L1 preadipocytes

Acta Academiae Medicinae Sinicae

Volumn 32, Issue 3, 2010, Pages 283-288

  Zhang, Shao Jun ^a   Gong, Feng Ying ^a   Deng, Jie Ying ^a   Zhu, Hui Juan ^a   Pan, Hui ^a   Zhang, Dian Xi ^a   Li, Nai Shi ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

3T3 L1 preadipocytes; Plasmid construction; Small interferencing RNA; Zinc 2 glycoprotein

Indexed keywords

ALPHA2 GLYCOPROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ZINC; ZINC ALPHA2 GLYCOPROTEIN; SEMINAL PLASMA PROTEIN; ZN ALPHA 2 GLYCOPROTEIN; ZN-ALPHA-2-GLYCOPROTEIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE SEQUENCE; LIVER; MOUSE; NONHUMAN; PLASMID; PROADIPOCYTE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ADIPOCYTE; ANIMAL; CELL STRAIN 3T3; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; METABOLISM;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; GENETIC VECTORS; MICE; PLASMIDS; RNA, SMALL INTERFERING; SEMINAL PLASMA PROTEINS; TRANSFECTION;

EID: 77954698237     PISSN: 1000503X     EISSN: None     Source Type: Journal    
DOI: 10.3881/j.issn.1000-503X.2010.03.010     Document Type: Article

References (12)

1. Marrades MP, Martinez JA, Moreno-Aliaga MJ. ZAG, a lipid mobilizing adipokine, is downregulated in human obesity [J]. J Physiol Biochem, 2008, 64(1):61-66.
2. Mracek T, Ding Q, Tzanavari T, et al. The adipokine zinc-alpha2- glycoprotein (ZAG) is downregulated with fat mass expansion in obesity [J]. Clin Endocrinol (Oxf), 2010, 72(3):334-341.
3. Bing C, Trayhurn P. New insights into adipose tissue atrophy in cancer cachexia [J]. Proc Nutr Soc, 2009, 68(4):385-392.
4. Hassan MI, Waheed A, Yadav S, et al. Zinc alpha2-glycoprotein: a multidisciplinary protein [J]. Mol Cancer Res, 2008, 6(6):892-906.
5. Gong FY, Deng JY, Shi YF. Effect of interleukin-1 beta on growth hormone gene expression and its possible molecular mechanism in rat MtT/S somatotroph cells [J]. Chin Med Sci J, 2008, 23(4):193-201.
6. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T)) Method [J]. Methods, 2001, 25(4):402-408.
7. Gong FY, Shi YF, Deng JY. The regulatory mechanism by which interleukin-6 stimulates GH-gene expression in rat GH3 cells [J]. J Endocrinol, 2006, 190(2):397-406.
8. Hirai K, Hussey HJ, Barber MD, et al. Biological evaluation of a lipid mobilizing factor isolated from the urine of cancer patiente [J]. Cancer Res, 1998, 58(11):2359-2365.
9. Gohda T, Makita Y, Shike T, et al. Identification of epistatic interaction involved in obesity using the KK/Ta mouse as a Type 2 diabetes model: is Zn-alpha2 glycoprotein-1 a candidate gene for obesity [J]. Diabetes, 2003, 52(8):2175-2181.
10. Goyal BR, Patel MM, Soni MK, et al. Therapeutic opportunities of small interfering RNA [J]. Fundam Clin Pharmacol, 2009, 23(4):367-386.
11. Ikeda D, Sakaue S, Kamigaki M, et al. Knockdown of macrophage migration inhibitory factor disrupts adipogenesis in 3T3-L1 cells [J]. Endocrinology, 2008, 149(12):6037-6042.
12. Puri V, Virbasius JV, Guilherme A, et al. RNAi screens reveal novel metabolic regulators: RIP140, MAP4k4 and the lipid droplet associated fat specific protein (FSP) 27 [J]. Acta Physiol (Oxf), 2008, 192(1):103-115.